[Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
Rudling
Mats
M
Kliniken för endokrinologi, metabolism och diabetes, institutionen för medicin, Karolinska Universitetssjukhuset Huddinge, samt Centrum för nutrition och toxikologi, Novum, Stockholm mats.rudling@cnt.ki.se
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood* / Q000378:metabolism; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control; D012016:Reference Values; D012307:Risk Factors; D013997:Time Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL